AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 166 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,609 | +58.3% | 849 | +7.3% | 0.00% | – |
Q1 2024 | $23,129 | +38.5% | 791 | +5.5% | 0.00% | – |
Q4 2023 | $16,703 | -10.1% | 750 | -0.1% | 0.00% | – |
Q3 2023 | $18,587 | -12.6% | 751 | 0.0% | 0.00% | – |
Q2 2023 | $21,268 | +193245.5% | 751 | +54.8% | 0.00% | – |
Q1 2023 | $11 | -78.0% | 485 | -72.8% | 0.00% | – |
Q4 2022 | $50 | -99.9% | 1,785 | 0.0% | 0.00% | – |
Q3 2022 | $49,000 | +25.6% | 1,785 | +2.6% | 0.00% | – |
Q2 2022 | $39,000 | +200.0% | 1,740 | +295.5% | 0.00% | – |
Q1 2022 | $13,000 | -75.5% | 440 | -74.3% | 0.00% | – |
Q4 2021 | $53,000 | -59.5% | 1,710 | -39.6% | 0.00% | -100.0% |
Q3 2021 | $131,000 | -16.0% | 2,830 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $156,000 | +7.6% | 2,830 | +1.1% | 0.00% | 0.0% |
Q1 2021 | $145,000 | +457.7% | 2,800 | +366.7% | 0.00% | – |
Q4 2020 | $26,000 | -69.8% | 600 | -75.6% | 0.00% | -100.0% |
Q3 2020 | $86,000 | +168.8% | 2,458 | +309.7% | 0.00% | – |
Q2 2020 | $32,000 | +52.4% | 600 | 0.0% | 0.00% | – |
Q1 2020 | $21,000 | -90.2% | 600 | -87.1% | 0.00% | -100.0% |
Q4 2018 | $214,000 | -40.2% | 4,642 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $358,000 | +4375.0% | 4,642 | +2221.0% | 0.00% | – |
Q1 2016 | $8,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |